3 results match your criteria: "Hypertension Institute of Xinjiang China[Affiliation]"
Medicine (Baltimore)
September 2019
Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang China, Urumqi, Xinjiang, China.
Hypertension is a common global health problem including China. This study aimed to assess the prevalence and awareness of hypertension, and evaluate risk factors associated with hypertension among multi-ethnic population in northwest China using a random sampling cross-sectional data.A cross-sectional survey was conducted between 2014 and 2015 as part of a nationwide survey using stratified four-stage random sampling in Xinjiang.
View Article and Find Full Text PDFJ Interferon Cytokine Res
September 2018
The Center for Hypertension of the People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang China, Xinjiang, China .
Monocyte chemotactic protein 1 (MCP-1) plays a significant role in inflammation pathways by affecting monocyte/macrophage migration, the number of monocytes and T lymphocytes, and osmosis. Inflammation is closely linked to various types of systematic vasculitis. Here we characterized serum MCP-1 levels in systemic vasculitis patients.
View Article and Find Full Text PDFGenet Mol Res
February 2015
Hypertension Institute of Xinjiang China, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China
We investigated the relationship between the polymorphism of SOCS-3 and dyslipidemia of people from Uygur in Xinjiang, China. This cross-sectional study included 1379 participants in a Hetian Xinjiang Uygur population who were 30-70 years of age and were not from interracial marriages of 3 generations; all subjects were genotyped (909 dyslipidemia subjects, 470 healthy subjects). Allele (P = 0.
View Article and Find Full Text PDF